Pediatric Stem Cell Transplant Recipients Are Resilient

This article originally appeared here.
Share this content:
Pediatric Stem Cell Transplant Recipients Are Resilient
Pediatric Stem Cell Transplant Recipients Are Resilient

(HealthDay News) – Pediatric patients undergoing stem cell transplantation (SCT) have a positive overall adjustment and health-related quality of life (HRQL), according to a study published online February 6 in Pediatrics.

Sean Phipps, PhD, of the St. Jude Children's Research Hospital in Memphis, TN, and colleagues studied 171 pediatric patients undergoing SCT and their parents who were randomized to receive a child-targeted intervention, a child and parent intervention, or standard care. The child intervention was made up of massage and humor therapy, while the parent intervention included massage and relaxation/imagery. Symptoms of depression and posttraumatic stress, HRQL, and benefit finding were measured. Patient and parents were assessed at admission and 24 weeks after SCT.

The researchers found that significant improvements were seen on all outcomes from admission through follow-up. Patients who had SCT reported low levels of adjustment difficulties at admission, and by the end of follow-up they had improved to normal or better than average levels of adjustment and HRQL. Benefit finding was high at admission and also increased at follow-up. No statistically significant differences were seen for any of the measures between the intervention arms.

"Although the results do not support the benefits of these complementary interventions in pediatric SCT, this may be explained by the remarkably positive overall adjustment seen in this sample," the authors write.

Abstract
Full Text (subscription or payment may be required)

Related Resources

You must be a registered member of Cancer Therapy Advisor to post a comment.

Sign Up for Free e-newsletters



Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs